Literature DB >> 29524085

A Literature Review of Blood-Disseminated P. marneffei Infection and a Case Study of this Infection in an HIV-Negative Child with Comorbid Eosinophilia.

Xiu-Jing Han1,2, Dan-Hong Su3, Jian-Yun Yi3, Ya-Wei Zou4, Yu-Ling Shi5,6.   

Abstract

BACKGROUND: The typical manifestations of Penicillium marneffei (nowadays Talaromyces marneffei) infection in children without human immunodeficiency virus (HIV) remain unclear. The current work presents the case of a child without an underlying disease who was infected with P. marneffei comorbid with eosinophilia. CASE
PRESENTATION: A 2-year-old male was infected with P. marneffei. A physical examination revealed a high-grade fever, ulcerated lesions in the oral mucosa, anemia, pruritic erythematous papules on the sac and thigh and watery diarrhea. A chest enhanced computed tomography scan showed multiple small, nodular, high-density shadows in the lungs, multiple lymphadenectasis in the hilum of the lungs and mediastinum, and liquid in the right pleural cavity. The patient's plasma was negative for HIV. Routine blood tests initially indicated that the patient had leucopenia; however, later tests indicated that he had leukocytosis. This peak was caused by a significant increase in eosinophils. The total IgE and specific allergen levels were normal. The stool was negative for parasite eggs. Aspergillus antigen (galactomannan, GM) levels were significantly increased and were present in the serum for a relatively long period.
CONCLUSIONS: Eosinophilia can occur during P. marneffei infection, and this finding might provide additional information on the activity of this intracellular parasite. In addition, GM detection might be useful for monitoring the effect of antifungal treatments; however, this theory requires more data for verification.

Entities:  

Keywords:  Child; Eosinophilia; HIV-negative; Infection; P. marneffei (T. marneffei)

Mesh:

Substances:

Year:  2018        PMID: 29524085     DOI: 10.1007/s11046-018-0255-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  6 in total

1.  Characteristics and Prognosis of Talaromyces marneffei Infection in Non-HIV-Infected Children in Southern China.

Authors:  Jing Guo; Bing-Kun Li; Tian-Min Li; Fang-Lin Wei; Yu-Jiao Fu; Yan-Qing Zheng; Kai-Su Pan; Chun-Yang Huang; Cun-Wei Cao
Journal:  Mycopathologia       Date:  2019-08-31       Impact factor: 2.574

Review 2.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

3.  Sixty Years from Segretain's Description: What Have We Learned and Should Learn About the Basic Mycology of Talaromyces marneffei?

Authors:  Chi-Ching Tsang; Susanna K P Lau; Patrick C Y Woo
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

4.  Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces marneffei Infection in HIV-Negative Children.

Authors:  Pamela P Lee; Mongkol Lao-Araya; Jing Yang; Koon-Wing Chan; Haiyan Ma; Lim-Cho Pei; Lin Kui; Huawei Mao; Wanling Yang; Xiaodong Zhao; Muthita Trakultivakorn; Yu-Lung Lau
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

5.  Diagnosis by metagenomic next-generation sequencing of a Talaromyces marneffei bloodstream infection in an HIV-negative child: A case report.

Authors:  Aimei Yang; Yan Hu; Peiling Chen; Guilang Zheng; Xuejiao Hu; Jingwen Zhang; Jing Wang; Chun Wang; Zijian Huang; Yuxin Zhang; Yuxiong Guo
Journal:  Front Pediatr       Date:  2022-08-15       Impact factor: 3.569

Review 6.  Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.

Authors:  Shanti Narayanasamy; John Dougherty; H Rogier van Doorn; Thuy Le
Journal:  Mycopathologia       Date:  2021-07-06       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.